95 search results for: pediatric

Carolina Gutiérrez Junquera
Expert
Carolina Gutiérrez Junquera, MD, PhD

Carolina Gutiérrez Junquera, MD, PhD, is an associate professor of Pediatrics at the Universidad Autónoma of Madrid, Spain, and a consultant pediatric gastroenterologist at University Hospital Puerta de Hierro Majadahonda in Madrid.

Alexandra Papadopoulou
Expert
Alexandra Papadopoulou, MD

Chief of the Division of Pediatric Gastroenterology and Hepatology of the First Department of Pediatrics | National and Kapodistrian University of Athens; Head of the Gastroenterology Department | Children’s Hospital Agia Sofia, Athens, Greece

How Biologic Therapy May Lead to Disease Modification in Infants and Children with Atopic Dermatitis
Congress
8
April
2025
Congress
ADVENT at WCPD 2025

The ADVENT symposium at the 15th World Congress of Pediatric Dermatology (WCPD) will focus on discussions around disease modification in atopic dermatitis (AD) in three main topic areas: restoring the skin barrier, reducing non-atopic comorbidities, and stopping the atopic march in pediatric patients with AD aged 6 months to 11 years.

The Benefits of Early Intervention in Reducing the Burden of Disease in Children With Atopic Dermatitis
On Demand
The Benefits of Early Intervention in Reducing the Burden of Disease in Children With Atopic Dermatitis

This page presents educational material, infographics, and video highlights from our recent ADVENT symposia, including the 2025 World Congress of Pediatric Dermatology (WCPD) in Buenos Aires, Argentina, exploring the pathophysiology of type 2 inflammation and atopic dermatitis, the burden of disease leading to cumulative life course impairment (CLCI), and the risk of the atopic march in pediatric patients with atopic dermatitis.

.
Congress
9
March
2024
Congress
The Benefits of Early Intervention in AD: More Than Skin Deep

Many AD treatment goals focus on clinical manifestations, so that if a patient is free of lesions, their disease is considered well controlled. However, the inflammatory process underlying AD reaches far beyond the skin, affecting patients in unique ways at different stages of their lives. Education on the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient will help improve clinical management and reduce long-term patient burden.

Jerry Ellen Schonfeld
Expert
Jerry Ellen Schonfeld, CPNP

Certified Pediatric Nurse Practitioner

Eckard Hamelmann
Expert
Eckard Hamelmann, MD, PhD

Professor of Pediatrics | Evangelic Hospital, Bielefeld, Germany

Marlies de Graaf
Expert
Marlies de Graaf, MD, PhD

Pediatric Dermatologist, University Medical Center of Utrecht, The Netherlands

Monika Gappa
Expert
Monika Gappa, MD, PhD

Professor of Pediatrics and Director | Children’s Hospital, Evangelisches Krankenhaus, Düsseldorf, Germany

Lisa Swanson
Expert
Lisa Swanson, MD

Dermatologist and Pediatric Dermatologist at Ada West Dermatology | Boise, Idaho, United States

Giorgio Piacentini
Expert
Giorgio Piacentini, MD, PhD

Functional Head of the UOS Pediatric Respiratory Disease Section | Verona Integrated University Hospital, Italy

Anna Belloni Fortina
Expert
Anna Belloni Fortina, MD

Head of Pediatric Dermatology and full Professor at the University of Padova Medical School, Italy